Home › Funds › Saturn V Capital Management LP › PCVX

Saturn V Capital Management LP position in PCVX

VAXCYTE INC · Health Care

Saturn V Capital Management LP reported holding 852,914 shares of PCVX (VAXCYTE INC) in its Q2 2026 13F filing — a position valued at US$49.6M, representing 7.11% of its reported portfolio and ranking #4 among its reported holdings. Saturn V Capital Management LP has disclosed PCVX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)852.91K sh
Reported value held$49.58M
Portfolio Weight7.11%
First reportedQ1 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Saturn V Capital Management LP's PCVX position evolved

Saturn V Capital Management LP first disclosed a stake in PCVX in Q1 2024 at 185,175 shares (US$12.6M). The position peaked in Q2 2026 at 852,914 shares, worth US$49.6M. Across 10 filings, Saturn V Capital Management LP increased the stake 7 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 852,914 shares valued at US$49.6M — an increase of 28,382 shares quarter over quarter.. Notable position changes include a 134% increase in Q2 2025 (shares rose 11% over the following quarter), a 45% increase in Q3 2025 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 185.18K $12.65M New
Q2 2024 215.68K $16.29M Add
Q3 2024 204.99K $23.42M Reduce
Q4 2024 204.28K $16.72M Hold
Q1 2025 232.29K $8.77M Add
Q2 2025 544.22K $17.69M Add
Q3 2025 788.44K $28.40M Add
Q4 2025 798.94K $36.86M Add
Q1 2026 824.53K $47.91M Add
Q2 2026 852.91K $49.58M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PCVX and 13F data

PCVX (VAXCYTE INC) is a Health Care company. 36 other funds we track also report a position in PCVX — the largest reported positions include Jupiter Topco LLC (US$1.04B), Janus Henderson Group (US$960.2M), T. Rowe Price Investment Management, Inc. (US$709.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PCVX

All PCVX fund holders →

FAQ

How long has Saturn V Capital Management LP held PCVX?

Saturn V Capital Management LP has disclosed PCVX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is Saturn V Capital Management LP's current position in PCVX?

As of Q2 2026, Saturn V Capital Management LP holds 852.91K shares of PCVX (VAXCYTE INC), valued at $49.58M, representing 7.11% of its reported portfolio and ranking #4.

Has Saturn V Capital Management LP been buying or selling PCVX?

In the latest 13F filing (Q2 2026), Saturn V Capital Management LP increased its position in PCVX. The position peaked in Q2 2026 at 852.91K shares.

Which other funds hold PCVX?

Other major institutional holders of PCVX include Jupiter Topco LLC, Janus Henderson Group, T. Rowe Price Investment Management, Inc., among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.